The lack of augmentation by aspirin of inhibition of platelet reactivity by ticlopidine

American Journal of Cardiology

Volumn 83, Issue 5, 1999, Pages 770-774

  Farrell, Timothy P ^a   Hayes, Kelly B ^a   Sobel, Burton E ^a   Schneider, David J ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 12A; CITRIC ACID; CLOPIDOGREL; COLLAGEN; ENOXAPARIN; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; PADGEM PROTEIN; PROSTAGLANDIN SYNTHASE; THROMBOXANE A2; TICLOPIDINE; TRYPSIN INHIBITOR;

ADULT; ANTICOAGULATION; ARTICLE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG SENSITIVITY; FLOW CYTOMETRY; HUMAN; HUMAN EXPERIMENT; INTERMETHOD COMPARISON; MALE; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION;

ADENOSINE DIPHOSPHATE; ADULT; ANALYSIS OF VARIANCE; ANTICOAGULANTS; ASPIRIN; CHEMOPREVENTION; CITRIC ACID; COLLAGEN; DRUG INTERACTIONS; ENOXAPARIN; FACTOR XIIA; FLOW CYTOMETRY; HUMANS; MALE; P-SELECTIN; PLANT PROTEINS; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; TICLOPIDINE; TRYPSIN INHIBITORS; ZEA MAYS;

EID: 0033105080     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00987-4     Document Type: Article

References (19)

1. Fuster V., Stein B., Ambrose J.A., Badimon L., Badimon J.J., Chesebro J.H. Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation. 82:(suppl 3):1990;II47-II59.
2. White H.D. Unmet therapeutic needs in the management of acute ischemia. Am J Cardiol. 80:1997;2B-10B.
3. Kamat S.G., Kleiman N.S. Platelets and platelet inhibitors in acute myocardial infarction. Cardiol Clin. 13:1995;435-447.
4. Roth G.J., Calverley D.C. Aspirin, platelets, and thrombosis theory and practice . Blood. 83:1994;885-898.
5. Fitzgerald G.A., Shipp E. Antiplatelet and anticoagulant drugs in coronary vascular disease. Ann Epidemiol. 2:1992;529-542.
6. Goel P.K., Shahi M., Agarwal A.K., Srivastava S., Seth P.K. Platelet aggregability and occurrence of restenosis following coronary angioplasty. Int J Cardiol. 60:1997;227-231.
7. Fitzgerald D.J., Roy L., Catella F., Fitzgerald G.A. Platelet activation in unstable coronary disease. N Engl J Med. 315:1986;983-989.
8. Trip M.D., Cats V.M., van Capelle F.J.L., Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med. 322:1990;1549-1554.
9. Thaulow E., Erikssen J., Sandvik L., Stormorken H., Cohn P.F. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation. 84:1991;613-617.
10. Lam J.Y.T., Latour J.-G., Lesperance J., Waters D. Platelet aggregation, coronary artery disease progression and future coronary events. Am J Cardiol. 73:1994;333-338.
11. Schuhlen H., Kastrati A., Dirschinger J., Hausleiter J., Elezi S., Wehinger A., Pache J., Hadamitzky M., Schomig A. Intracoronary stenting and risk for major adverse cardiac events during the first month. Circulation. 98:1998;104-111.
12. Schneider D.J., Tracy P.B., Mann K.G., Sobel B.E. Differential effects of anticoagulants on the activation of platelets ex vivo. Circulation. 96:1997;2877-2883.
13. McTavish D., Faulds D., Goa K.L. Ticlopidine. An updated review of its pharmacology and therapeutic use in platelet-dependent disorders. Drugs. 40:1990;238-259.
14. Gonzalez E.R. Antiplatelet therapy in atherosclerotic cardiovascular disease. Clin Ther. 20:(suppl B):1998;B18-B41.
15. Roth G.J., Majerus P.W. The mechanism of the effect of aspirin on human platelets I: acetylation of a particulate fraction protein . J Clin Invest. 56:1975;624-629.
16. Shimokawa T., Smith W.L. Prostaglandin endoperoxide synthase. The aspirin acetylation region. J Biol Chem. 267:1992;12387-12392.
17. Loll P.J., Picot D., Garavito R.M. The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase. Nat Struct Biol. 2:1995;637-643.
18. Rupprecht H.J., Darius H., Borkowski U., Voigtlander T., Nowak B., Genth S., Meyer J. Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation. Circulation. 97:1998;1046-1052.
19. Bossavy J.P., Thalamas C., Sagnard L., Barret A., Sakariassen K., Boneu B., Cadroy Y. A double-blind randomized comparison of combined aspirin and ticlopidine therapy versus aspirin or ticlopidine alone on experimental arterial thrombogenesis in humans. Blood. 92:1998;1518-1525.